Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Capital Expenditures (2016 - 2026)

Catalyst Pharmaceuticals filings provide 12 years of Capital Expenditures readings, the most recent being $27000.0 for Q1 2026.

  • On a quarterly basis, Capital Expenditures changed N/A to $27000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $85000.0, a 76.19% decrease, with the full-year FY2025 number at $58000.0, down 89.57% from a year prior.
  • Capital Expenditures hit $27000.0 in Q1 2026 for Catalyst Pharmaceuticals, down from $32000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $259000.0 in Q3 2024 to a low of $10000.0 in Q2 2024.
  • Median Capital Expenditures over the past 4 years was $69000.0 (2023), compared with a mean of $87200.0.
  • Biggest five-year swings in Capital Expenditures: soared 304.69% in 2024 and later crashed 63.64% in 2025.
  • Catalyst Pharmaceuticals' Capital Expenditures stood at $93000.0 in 2023, then dropped by 5.38% to $88000.0 in 2024, then crashed by 63.64% to $32000.0 in 2025, then fell by 15.62% to $27000.0 in 2026.
  • The last three reported values for Capital Expenditures were $27000.0 (Q1 2026), $32000.0 (Q4 2025), and $26000.0 (Q2 2025) per Business Quant data.